Evidence map›Paper›PMID 28515457›Full record

ArticleScientific reports2017

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.

Hung Yi Kristal Kaan, Siew Wee Chan, Siew Kim Joyce Tan, Fusheng Guo, Chun Jye Lim, Wanjin Hong, Haiwei Song

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Targeting TEAD in cancer.Frontiers in oncology · 2025
    Review
  9. Review
  10. YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.Journal of cancer research and clinical oncology · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hung Yi Kristal KaanInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore.
Siew Wee ChanInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore.
Siew Kim Joyce TanInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore.
Fusheng GuoInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore.
Chun Jye LimInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore.
Wanjin HongInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore. mcbhwj@imcb.a-star.edu.sg.
Haiwei SongInstitute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Resesarch), 61 Biopolis Drive, Singapore, 138673, Singapore. haiwei@imcb.a-star.edu.sg.
Agency for Science, Technology and Research · SGInstitute of Molecular and Cell Biology · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hippo pathway is a tumor suppressor pathway that is implicated in the regulation of organ size. The pathway has three components: the upstream regulatory factors, the kinase core, and the downstream transcriptional machinery, which consists of YAP, TAZ (transcription co-activators) and TEAD (transcription factor). Formation of YAP/TAZ-TEAD complexes leads to the transcription of growth-promoting genes. Herein, we report the crystal structure of TAZ-TEAD4 complex, which reveals two binding modes. The first is similar to the published YAP-TEAD structure. The second is a unique binding mode, whereby two molecules of TAZ bind to and bridge two molecules of TEAD4. We validated the latter using cross-linking and multi-angle light scattering. Using siRNA, we showed that TAZ knockdown leads to a decrease in TEAD4 dimerization. Lastly, results from luciferase assays, using YAP/TAZ transfected or knockdown cells, give support to the non-redundancy of YAP/TAZ co-activators in regulating gene expression in the Hippo pathway.

Indexed as

Models, MolecularProtein ConformationAcyltransferasesAdaptor Proteins, Signal TransducingAnimalsBinding SitesCell Cycle ProteinsDNA-Binding ProteinsMiceMuscle ProteinsPhosphoproteinsProtein BindingProtein Interaction Domains and MotifsProtein MultimerizationRecombinant Fusion ProteinsStructure-Activity RelationshipAcyltransferasesAdaptor Proteins, Signal TransducingCell Cycle ProteinsDNA-Binding ProteinsMuscle ProteinsPhosphoproteinsRecombinant Fusion Proteinstafazzin protein, mouseTead4 protein, mouseTEA Domain Transcription FactorsTranscription FactorsYap1 protein, mouseYAP-Signaling Proteins

Identifiers

PMID28515457
PMCPMC5435683
OpenAlexW2612611322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.